Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E CLARKE

Showing results (111-120 of 1,497) with videos related to

Pageof 150
Sort By:
Gerontology|February 15, 2002
Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve themP W Overstall, C E Clarke
European Journal of Pharmacology|July 10, 1981
An alpha-adrenoceptor inhibitory action of kynuramineT D Johnson, D E Clarke
British Journal of Pharmacology|March 1, 1976
Blood pressure responses to adrenal field stimulation as a measure of adrenal catecholamine releaseD E Clarke, W M Romanyshyn
The Cochrane Database of Systematic Reviews|May 5, 2000
Lisuride for levodopa-induced complications in Parkinson's diseaseC E Clarke, J M Speller
Journal of Virology|January 15, 2003
In vivo induction of apoptosis correlating with reduced infectivity during baculovirus infectionThomas E Clarke, Rollie J Clem
International Journal of Hypertension|November 29, 2011
Angiotensin-converting enzyme 2: the first decadeNicola E Clarke, Anthony J Turner
Chest|April 1, 1990
Infectious complications of indwelling long-term central venous cathetersD E Clarke, T A Raffin
The Cochrane Database of Systematic Reviews|May 2, 2001
Ropinirole for levodopa-induced complications in Parkinson's diseaseC E Clarke, K H Deane
The Cochrane Database of Systematic Reviews|July 25, 2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's diseaseC E Clarke, K H Deane
European Journal of Pharmacology|March 3, 1992
Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagusG S Baxter, D E Clarke
Pageof 150

Showing results (111-120 of 1,497) with videos related to

Sort By:
Pageof 150
Gerontology|February 15, 2002
Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve themP W Overstall, C E Clarke
European Journal of Pharmacology|July 10, 1981
An alpha-adrenoceptor inhibitory action of kynuramineT D Johnson, D E Clarke
British Journal of Pharmacology|March 1, 1976
Blood pressure responses to adrenal field stimulation as a measure of adrenal catecholamine releaseD E Clarke, W M Romanyshyn
The Cochrane Database of Systematic Reviews|May 5, 2000
Lisuride for levodopa-induced complications in Parkinson's diseaseC E Clarke, J M Speller
Journal of Virology|January 15, 2003
In vivo induction of apoptosis correlating with reduced infectivity during baculovirus infectionThomas E Clarke, Rollie J Clem
International Journal of Hypertension|November 29, 2011
Angiotensin-converting enzyme 2: the first decadeNicola E Clarke, Anthony J Turner
Chest|April 1, 1990
Infectious complications of indwelling long-term central venous cathetersD E Clarke, T A Raffin
The Cochrane Database of Systematic Reviews|May 2, 2001
Ropinirole for levodopa-induced complications in Parkinson's diseaseC E Clarke, K H Deane
The Cochrane Database of Systematic Reviews|July 25, 2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's diseaseC E Clarke, K H Deane
European Journal of Pharmacology|March 3, 1992
Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagusG S Baxter, D E Clarke
Pageof 150